ID24101A - Turunan-turunan triazolobenzazepine trisiklik, proses pembuatan yang sama, dan zat-zat antialergi - Google Patents

Turunan-turunan triazolobenzazepine trisiklik, proses pembuatan yang sama, dan zat-zat antialergi

Info

Publication number
ID24101A
ID24101A IDW20000808A ID20000808A ID24101A ID 24101 A ID24101 A ID 24101A ID W20000808 A IDW20000808 A ID W20000808A ID 20000808 A ID20000808 A ID 20000808A ID 24101 A ID24101 A ID 24101A
Authority
ID
Indonesia
Prior art keywords
tricyclic
triazolobenzazepine
antialergy
derives
substance
Prior art date
Application number
IDW20000808A
Other languages
English (en)
Indonesian (id)
Inventor
Yasuo Ohtsuka
Toshio Nishizuka
Sohjiro Shiokawa
Seiji Tsutsumi
Mami Kawaguchi
Hideo Kitagawa
Hiromi Takata
Takashi Shishikura
Toyoaki Ishikura
Kenichi Fushihara
Yumiko Okada
Sachiko Miyamato
Maki Shiobara
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of ID24101A publication Critical patent/ID24101A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW20000808A 1997-09-29 1998-09-29 Turunan-turunan triazolobenzazepine trisiklik, proses pembuatan yang sama, dan zat-zat antialergi ID24101A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26461197 1997-09-29
JP5206398 1998-03-04

Publications (1)

Publication Number Publication Date
ID24101A true ID24101A (id) 2000-07-06

Family

ID=26392670

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000808A ID24101A (id) 1997-09-29 1998-09-29 Turunan-turunan triazolobenzazepine trisiklik, proses pembuatan yang sama, dan zat-zat antialergi

Country Status (24)

Country Link
US (3) US6372735B1 (es)
EP (1) EP1026167B1 (es)
JP (1) JP3188482B2 (es)
KR (1) KR100389140B1 (es)
CN (2) CN1155599C (es)
AT (1) ATE233764T1 (es)
AU (1) AU744636B2 (es)
BR (1) BR9814055B1 (es)
CA (1) CA2305307C (es)
DE (1) DE69811930T2 (es)
DK (1) DK1026167T3 (es)
ES (1) ES2191963T3 (es)
HU (1) HUP0004020A3 (es)
ID (1) ID24101A (es)
IL (1) IL135303A0 (es)
NO (2) NO319542B1 (es)
NZ (1) NZ503601A (es)
PL (1) PL339544A1 (es)
PT (1) PT1026167E (es)
RU (1) RU2198885C2 (es)
SK (1) SK283869B6 (es)
TR (1) TR200000808T2 (es)
TW (1) TW510902B (es)
WO (1) WO1999016770A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60229298D1 (de) * 2001-12-26 2008-11-20 Meiji Seika Kaisha Neues kristallines tricyclisches triazolobenzazepinderivat
DE60313124T2 (de) 2002-02-01 2007-08-23 Meiji Seika Kaisha Ltd. Verfahren zur herstellung einer 1,2,3-triazolverbindung
US6875782B2 (en) 2002-07-09 2005-04-05 Bristol-Myers Squibb Company Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
JP4579681B2 (ja) 2002-07-09 2010-11-10 ブリストル−マイヤーズ スクイブ カンパニー 抗糖尿病薬および抗肥満薬として有用な置換ヘテロシクロ誘導体および方法
US20070167432A1 (en) * 2003-06-19 2007-07-19 Meiji Seila Kaisha, Ltd Tricyclic triazolobenzapine derivative produced as novel crystalline substance
JPWO2004113451A1 (ja) * 2003-06-20 2006-08-17 明治製菓株式会社 難溶性物質と水溶性高分子との共沈物およびその製造方法
KR101792651B1 (ko) 2004-05-14 2017-11-20 밀레니엄 파머슈티컬스 인코퍼레이티드 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 화합물을 포함하는 약학적 조성물
EP1994931A4 (en) * 2006-03-02 2010-12-01 Meiji Seika Kaisha PROPHYLACTIC OR THERAPEUTIC AGENT FOR ALLERGIC EYE DISEASES OR ALLERGIC NOSES DISEASES WITH A TRICOLOZENZOAZEPINE DERIVATIVE TRICYCLIC
WO2008040332A1 (de) * 2006-09-25 2008-04-10 Forschungsverbund Berlin E.V. Strukturmimetika prolinreicher peptide und ihre pharmazeutische verwendung
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
KR101216756B1 (ko) * 2007-12-18 2012-12-28 메이지 세이카 파루마 가부시키가이샤 염증성 장질환의 예방 또는 치료제
CN102264368B (zh) 2008-12-22 2014-09-10 米伦纽姆医药公司 极光激酶抑制剂与抗cd20抗体的组合
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
EP2521545B1 (en) * 2010-01-07 2019-11-27 Alkermes Pharma Ireland Limited Prodrugs of heteroaromatic compounds
WO2011103089A1 (en) 2010-02-19 2011-08-25 Millennium Pharmaceuticals, Inc. Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
EP2976086B1 (en) 2013-03-22 2020-10-14 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
EP3324976A4 (en) 2015-07-21 2019-03-27 Millennium Pharmaceuticals, Inc. ADMINISTRATION OF KINASE AURORA INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
BR112020013073A2 (pt) * 2017-12-29 2020-12-01 Biomarin Pharmaceutical Inc. composto, composto, estereoisômero único ou mistura de estereoisômeros ou sal farmaceuticamente aceitável, composição farmacêutica, método de tratamento de uma doença ou distúrbio e composto ou sal farmaceuticamente aceitável do mesmo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0646570B1 (en) 1993-04-16 1998-06-24 Shionogi & Co., Ltd. Process for producing lignan compound
DE69427023T2 (de) * 1993-12-28 2001-10-31 Meiji Seika K.K., Tokio/Tokyo Tricyclische benzazepin-und benzothiazepin derivate
KR100286494B1 (ko) * 1995-06-15 2001-04-16 이치로 키타사토 삼환성벤즈아제핀화합물
EP0888350A1 (en) * 1996-03-08 1999-01-07 Zeneca Limited Azolobenzazepine derivatives as neurologically active agents
US20070059533A1 (en) * 2005-09-12 2007-03-15 Burdette Steven R Thermal reflow of glass and fused silica body

Also Published As

Publication number Publication date
BR9814055B1 (pt) 2009-05-05
SK283869B6 (sk) 2004-03-02
US20060074074A1 (en) 2006-04-06
HUP0004020A3 (en) 2002-12-28
US6372735B1 (en) 2002-04-16
NZ503601A (en) 2002-02-01
DE69811930T2 (de) 2003-12-18
KR100389140B1 (ko) 2003-06-25
AU9186998A (en) 1999-04-23
NO319542B1 (no) 2005-08-29
CA2305307C (en) 2004-11-30
IL135303A0 (en) 2001-05-20
NO20043765L (no) 2000-05-18
CN1278262A (zh) 2000-12-27
TR200000808T2 (tr) 2000-08-21
AU744636B2 (en) 2002-02-28
KR20010030784A (ko) 2001-04-16
PL339544A1 (en) 2000-12-18
RU2198885C2 (ru) 2003-02-20
NO20001500D0 (no) 2000-03-23
US7022860B2 (en) 2006-04-04
DE69811930D1 (de) 2003-04-10
HK1032782A1 (en) 2002-08-30
HUP0004020A2 (hu) 2001-09-28
US20020137739A1 (en) 2002-09-26
WO1999016770A1 (en) 1999-04-08
CN1312135C (zh) 2007-04-25
ATE233764T1 (de) 2003-03-15
EP1026167A4 (en) 2001-07-11
DK1026167T3 (da) 2003-05-26
JP3188482B2 (ja) 2001-07-16
NO20001500L (no) 2000-05-18
BR9814055A (pt) 2000-09-26
EP1026167B1 (en) 2003-03-05
ES2191963T3 (es) 2003-09-16
CN1523019A (zh) 2004-08-25
US7238812B2 (en) 2007-07-03
PT1026167E (pt) 2003-07-31
TW510902B (en) 2002-11-21
CA2305307A1 (en) 1999-04-08
EP1026167A1 (en) 2000-08-09
SK4252000A3 (en) 2000-10-09
CN1155599C (zh) 2004-06-30

Similar Documents

Publication Publication Date Title
IL135303A0 (en) Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents
FI956270A0 (fi) Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi
IL113313A (en) Heterocyclic compounds and pharmaceutical compositions containing the same
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
BG106340A (en) Substituted oxoazaheterocyclyl compounds
HUT63155A (en) Process for producing substituted taxane derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT74182A (en) Novel imidazole derivatives, process for producing the same and pharmaceutical compositions containing the compounds
BR9805734A (pt) Derivados de imidazolin-4-ona úteis como agentes anticancerìgenos.
PT868182E (pt) Processo para a producao de derivados de piperidina
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
AU3274997A (en) Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
IL113778A0 (en) Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof
EP1094055A4 (en) NEW VINYLBENZENE DERIVATIVES
WO1999021848A3 (en) Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
DE69319859D1 (de) Neue tetracyclische verbindungen
EP1197211A4 (en) CANCER PREVENTION AND TREATMENT ACTIVE INGREDIENTS
AU7332996A (en) Therapeutics for thrombocytopenia
AR017971A1 (es) DERIVADOS TRICíCLICOS DE TRIAZOLBENZAZEPINAS, PROCEDIMIENTO PARA PRODUCIR LOS MISMOS, COMPOSICIONES FARMACEUTICAS FORMULADAS CON DICHOS COMPUESTOS Y COMPUESTOS INTERMEDIARIOS DE APLICACION EN DICHO PROCEDIMIENTO Y LA PEPARACION DE LOS MISMOS.
AU2639999A (en) Intermediate compounds in the synthesis of the a ring moiety of 2-substituted vitamin d derivatives
TW430666B (en) New 5H-thiazolo[3,2-a]pyrimidin-5-one derivatives
EP1251129A4 (en) PYRIMIDINE DERIVATIVES WITH ANTI-TUMOR EFFECT